Changes were further confirmed by the decreased mRNA levels of UCP1 and PGC1α (Fig. 2e, f) and diminished UCP1, PGC1α, and Cidea protein expressions in CAD patients (Fig. 2c and d). This evidence concerns the gene CIDEA and coronary artery disorder.